Never mind the semantics—the salient point is that any FDA response to an ANDA other than an outright approval might mean years of further work by the applicant, and ultimate approval is not assured even then.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”